Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica H Brittain

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|February 20, 2016
Finite sample pointwise confidence intervals for a survival distribution with right-censored dataMichael P Fay, Erica H Brittain
Clinical Trials (London, England)|July 2, 2016
Comments on Berry et al.'s response-adaptive randomization platform trial for EbolaErica H Brittain, Michael A Proschan
Statistics in Medicine|February 28, 2020
A primer on strong vs weak control of familywise error rateMichael A Proschan, Erica H Brittain
Biostatistics (Oxford, England)|April 3, 2012
A valid formulation of the analysis of noninferiority trials under random effects meta-analysisErica H Brittain, Michael P Fay, Dean A Follmann
Clinical Trials (London, England)|March 27, 2010
Does treatment effect depend on control event rate? Revisiting a meta-analysis of suicidality and antidepressant use in childrenMichael A Proschan, Erica H Brittain, Michael P Fay
Biostatistics (Oxford, England)|May 2, 2013
Pointwise confidence intervals for a survival distribution with small samples or heavy censoringMichael P Fay, Erica H Brittain, Michael A Proschan
Clinical Trials (London, England)|February 16, 2026
Event-driven planning of two-armed trials with a binary endpointErica H Brittain, Raphaël N Morsomme, Michael A Proschan
Statistics in Medicine|May 19, 2018
Causal estimands and confidence intervals associated with Wilcoxon-Mann-Whitney tests in randomized experimentsMichael P Fay, Erica H Brittain, Joanna H Shih, et al.
The Journal of Allergy and Clinical Immunology. Global|June 18, 2025
Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trialHirsh D Komarow, Jing Wang, Robin Eisch, et al.
The American Statistician|January 25, 2021
On Causal Inferences for Personalized Medicine: How Hidden Causal Assumptions Led to Erroneous Causal Claims About the D-ValueSander Greenland, Michael P Fay, Erica H Brittain, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|February 20, 2016
Finite sample pointwise confidence intervals for a survival distribution with right-censored dataMichael P Fay, Erica H Brittain
Clinical Trials (London, England)|July 2, 2016
Comments on Berry et al.'s response-adaptive randomization platform trial for EbolaErica H Brittain, Michael A Proschan
Statistics in Medicine|February 28, 2020
A primer on strong vs weak control of familywise error rateMichael A Proschan, Erica H Brittain
Biostatistics (Oxford, England)|April 3, 2012
A valid formulation of the analysis of noninferiority trials under random effects meta-analysisErica H Brittain, Michael P Fay, Dean A Follmann
Clinical Trials (London, England)|March 27, 2010
Does treatment effect depend on control event rate? Revisiting a meta-analysis of suicidality and antidepressant use in childrenMichael A Proschan, Erica H Brittain, Michael P Fay
Biostatistics (Oxford, England)|May 2, 2013
Pointwise confidence intervals for a survival distribution with small samples or heavy censoringMichael P Fay, Erica H Brittain, Michael A Proschan
Clinical Trials (London, England)|February 16, 2026
Event-driven planning of two-armed trials with a binary endpointErica H Brittain, Raphaël N Morsomme, Michael A Proschan
Statistics in Medicine|May 19, 2018
Causal estimands and confidence intervals associated with Wilcoxon-Mann-Whitney tests in randomized experimentsMichael P Fay, Erica H Brittain, Joanna H Shih, et al.
The Journal of Allergy and Clinical Immunology. Global|June 18, 2025
Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trialHirsh D Komarow, Jing Wang, Robin Eisch, et al.
The American Statistician|January 25, 2021
On Causal Inferences for Personalized Medicine: How Hidden Causal Assumptions Led to Erroneous Causal Claims About the D-ValueSander Greenland, Michael P Fay, Erica H Brittain, et al.
Pageof 2